Cvs Pharmacy #16565 Durable Medical Equipment & Medical Supplies Location: 1370 Highway 15 S, Hutchinson, Minnesota 55350 Phone: (320) 587-9576 |
Wal-mart Pharmacy 10-1738 Durable Medical Equipment & Medical Supplies Location: 1300 Highway 15 S, Hutchinson, Minnesota 55350 Phone: (320) 587-1023 |
Thrifty White Pharmacy #793 Durable Medical Equipment & Medical Supplies Location: 1460 Montreal St Se, Hutchinson, Minnesota 55350 Phone: (320) 587-2509 |
Cash Wise Pharmacy #3011 DME Supplier - Customized Equipment Location: 1020 Highway 15 S, Hutchinson, Minnesota 55350 Phone: (800) 846-7434 |
Walgreens #15680 Durable Medical Equipment & Medical Supplies Location: 945 Highway 15 S, Hutchinson, Minnesota 55350 Phone: (320) 234-9499 |
Allina Health System Durable Medical Equipment & Medical Supplies Location: 1077 Highway 15 S, Hutchinson, Minnesota 55350 Phone: (320) 234-5110 |
Rebound Orthotics & Prosthetics Prosthetic/Orthotic Supplier Location: 1073 Highway 15 S Plaza 15, Hutchinson, Minnesota 55350 Phone: (320) 587-4144 |
Primary Eyecare Eyewear Supplier (Equipment, not the service) Location: 1059 Highway 15 S, Hutchinson, Minnesota 55350 Phone: (320) 587-4744 |
News Archive
As the 2010 World Economic Forum on Africa begins Wednesday in Dar Es Salaam, Tanzania, advocates from more than 10 African countries plan to "stage a demonstration" highlighting the need for funding for HIV/AIDS and other diseases, health-e reports (Thom, 5/5).
For patients who have experienced a large stroke that cuts off blood supply to a large part of the brain, the use of standardized medical management protocol and surgery to decompress swelling can improve life expectancy, Mayo Clinic researchers found in a recent study.
On the football field, the hockey rink or wrestling mat, an athletes' head can take a beating - and a University of Michigan neurologist is leading the charge to help doctors who treat the brain better understand those sports injuries.
A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.
AbbVie presented new results from the Phase 3 GIFT-I study of its investigational, all-oral, interferon (IFN)- and ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir at the Annual Meeting of the Japan Society of Hepatology in Kumamoto, Japan.
› Verified 6 days ago